Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonate therapy

A A Licata1

  • 1Department of Endocrinology, The Cleveland Clinic Foundation, Ohio 44195, USA.

The American Journal of the Medical Sciences
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Bisphosphonates, synthetic bone resorption inhibitors, are effective in increasing bone density and reducing fractures. Different bisphosphonates offer varying potency and mechanisms for treating osteoporosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006
Same author

Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.

Bone·2006
Same author

Risedronate, a novel pyridinyl bisphosphonate for the treatment of osteoporosis and Paget's disease of bone.

Expert opinion on investigational drugs·2005
Same author

Tolerability of risedronate in postmenopausal women intolerant of alendronate.

Aging (Milan, Italy)·2002
Same author

Role of alendronate and risedronate in preventing and treating osteoporosis.

Cleveland Clinic journal of medicine·2001
Same author

Ultrasound of the skeleton: review of its clinical applications and pitfalls.

Current rheumatology reports·2001
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Area of Science:

  • Pharmacology
  • Biochemistry
  • Orthopedics

Background:

  • Bisphosphonates are synthetic pyrophosphate analogs that inhibit bone resorption.
  • Oral bisphosphonates share properties like poor absorption and potential GI irritation.
  • Each bisphosphonate exhibits a unique potency and mechanism of action.

Purpose of the Study:

  • To review the efficacy of various bisphosphonates in treating bone disorders.
  • To compare the therapeutic potential of different bisphosphonate agents.

Main Methods:

  • Review of multicentered trials and studies on bisphosphonate efficacy.
  • Analysis of clinical data on bone density and fracture rates.

Main Results:

Related Experiment Videos

  • Etidronate demonstrated success in increasing bone density and controlling fractures in osteoporosis.
  • Alendronate showed greater potency, increased bone density, and reduced fractures compared to etidronate.
  • Pamidronate (oral and IV), tiludronate, risedronate, and clodronate also show promise in improving bone density.

    • Conclusions:

    • Bisphosphonates are valuable therapeutic agents for bone diseases.
    • Different bisphosphonates offer a spectrum of efficacy for managing bone resorption and density.